Congo Begins Vaccination Campaign Against Fastest-Growing Ebola Outbreak in History
- The Democratic Republic of Congo began vaccinating its population against Ebola on Thursday, prioritizing healthcare workers and frontline workers with the Ervebo vaccine.
- As of Tuesday, the nation had recorded 5,713 confirmed cases with 2,744 deaths, concentrated primarily in Ituri province.
- The outbreak is spreading under extremely difficult conditions including insecurity, displacement, healthcare worker strikes, and intense population movement.
- Over 50,000 doses of Ervebo vaccine have been received, with 50,000 doses allocated to frontline workers and 20,000 doses designated for clinical trials to test effectiveness against the Bundibugyo virus causing the current outbreak.
- The WHO stated the outbreak remains out of control and is on track to surpass the 2014-2016 West African Ebola epidemic, which killed over 11,000 people.
The Democratic Republic of Congo launched a vaccination campaign against Ebola on Thursday, targeting the world's fastest-growing outbreak of the disease. Health Minister Roger Kamba announced the initiative in Kisangani, prioritizing healthcare workers and frontline personnel to receive the Ervebo vaccine, which has proven effective against previous Ebola outbreaks caused by different virus strains. Clinical trials are underway to test a vaccine specifically authorized for the current outbreak.
The current outbreak has become the deadliest in the country's history, with 5,713 confirmed cases and 2,744 deaths recorded by Tuesday. The virus is concentrated in Ituri province and spreading across six provinces in the eastern region under severe constraints, including armed conflict, population displacement, healthcare worker strikes, and significant population movements that complicate containment efforts.
More than 50,000 doses of Ervebo vaccine have been received, with 50,000 allocated to frontline workers and healthcare personnel, while 20,000 doses are reserved for clinical trials testing the vaccine's effectiveness against the Bundibugyo virus responsible for the current outbreak. The vaccine is being deployed under a compassionate use program, allowing its use despite lacking specific authorization for this particular virus. The WHO warned that the outbreak remains uncontrolled and is on pace to surpass the 2014-2016 West African Ebola epidemic, which killed over 11,000 people.
刚果民主共和国启动历史上增长最快的埃博拉疫情疫苗接种
刚果民主共和国周四启动了埃博拉疫苗接种运动，针对全球增长最快的疾病疫情。卫生部长罗杰·卡姆巴在基桑加尼宣布了这一举措，优先为卫生工作者和一线人员接种Ervebo疫苗，该疫苗已被证明对由不同病毒株引起的以往埃博拉疫情有效。临床试验正在进行中，以测试针对当前疫情的特定授权疫苗。
当前疫情已成为该国历史上最致命的疫情，截至周二已记录5,713例确诊病例和2,744例死亡。该病毒集中在伊图里省并在东部地区六个省份传播，面临严重制约，包括武装冲突、人口流离失所、卫生工作者罢工和大规模人口流动，这些都使防控工作复杂化。
已收到超过50,000剂Ervebo疫苗，其中50,000剂分配给一线工作人员和卫生工作者，20,000剂预留用于临床试验，以测试该疫苗对导致当前疫情的邦迪布吉病毒的有效性。该疫苗在人道主义使用计划下部署，允许其使用尽管缺乏针对这种特定病毒的具体授权。世卫组织警告称，疫情仍未得到控制，有望超过2014-2016年西非埃博拉疫情，后者造成超过11,000人死亡。